Citius Pharmaceuticals Inc (NAS:CTXR)
$ 0.4115 0.0293 (7.67%) Market Cap: 74.37 Mil Enterprise Value: 56.78 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 33/100

Citius Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 12, 2022 / 12:30PM GMT
Release Date Price: $1.32
Lander EgaÃ;a;GorroÃ;o
H.C. Wainwright & Co. LLC - Analyst

±-± -

Good morning, everyone, and welcome to the H.C. Wainwright 24th Annual Global Investment Hybrid Conference. My name is Lander, and I'm a Biotech Equity Research Associate at H.C. Wainwright. We're pleased to have you with us today, and it is now my pleasure to introduce our first presenter. Please join me in welcoming Leonard Mazur, CEO of Citius Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of critical care products. Leonard, please take it away.

Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO, and Chairman of the Board of Directors

Lander, thank you very much for the introduction. And also, I want to thank everybody that's here in person as well as those who are online with us. I want to thank you for taking the time out to be here with us. And also, just as an aside, I would also like to thank the New York City Port Authority and their bus system for the fact that I'm here because on my way

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot